Viewing Study NCT06435260


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2026-02-25 @ 5:44 PM
Study NCT ID: NCT06435260
Status: RECRUITING
Last Update Posted: 2025-06-26
First Post: 2024-05-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Hypofractionated Radiotherapy +Chemotherapy+ Camrelizumab as Neoadjuvant Therapy for Pancreatic Cancer
Sponsor: Hebei Medical University Fourth Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module